Cite
MLA Citation
Marco Colleoni et al.. “Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.” Lancet oncology, vol. 19, no. 1, 2018, pp. 127–138. http://access.bl.uk/ark:/81055/vdc_100055060662.0x00000d